tiprankstipranks
Aileron Therapeutics Inc (ALRN)
NASDAQ:ALRN

Aileron Therapeutics (ALRN) Financial Statements

1,174 Followers

Aileron Therapeutics Financial Overview

Aileron Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.386; its P/E ratio is -1.40; Aileron Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.34M$ -1.83M$ -1.79M$ -4.78M$ -4.37M
EBITDA$ -7.10M$ -1.82M$ -1.83M$ -4.84M$ -4.45M
Net Income Common Stockholders$ -7.34M$ -1.83M$ -1.79M$ -4.78M$ -4.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.31M$ 12.07M$ 13.69M$ 16.75M$ 21.27M
Total Assets$ 106.01M$ 12.82M$ 13.99M$ 17.16M$ 22.01M
Total Debt$ 48.00K$ 0.00$ 0.00$ 0.00$ 33.00K
Net Debt$ -17.27M$ -12.07M$ -13.69M$ -16.75M$ -21.23M
Total Liabilities$ 7.71M$ 1.62M$ 1.20M$ 2.88M$ 3.38M
Stockholders Equity$ 6.89M$ 11.20M$ 12.79M$ 14.27M$ 18.62M
Cash Flow-
Free Cash Flow$ -10.39M$ -1.60M$ -3.12M$ -4.66M$ -4.41M
Operating Cash Flow$ -10.39M$ -1.64M$ -3.12M$ -4.66M$ -4.41M
Investing Cash Flow$ -96.00K$ 542.00K$ 8.50M$ 7.25M$ 4.76M
Financing Cash Flow$ 15.79M----
Currency in USD

Aileron Therapeutics Earnings and Revenue History

Aileron Therapeutics Debt to Assets

Aileron Therapeutics Cash Flow

Aileron Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis